ESC 2020: EXPLORER-HCM: Mavacamten Proves Effective for Obstructive Hypertrophic Cardiomyopathy
The first-in-class agent targets underlying physiology directly.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.